DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD ...

Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

One of the best things about investing and trading in 2026 is that even the average retail trader has access to an unprecedented amount of data and analytical tools. Unfortunately, many of those ...

Discover how connecting make and test workflows can accelerate drug discovery by improving decision-making across the DMTA ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...